The new WHO guidance strengthens the fight against Plasmodium vivax malaria by combining safer radical cure medicines with routine G6PD testing to prevent dangerous side effects. By clearing both ...
On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results